comprehensive -WSS

comprehensive

author：leisure time 2025-09-28 00:53:32 - browse：28

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： House transparency, PBM reform bill gains bipartisan support

hotspot

WSS

How generative AI is inspiring dreams of a health data revolution

Streamlined flu vaccines recommended by FDA advisory panel

House transparency, PBM reform bill gains bipartisan support

Advances in CAR

For AI in health care standards, federal regulators join with industry group

State of the Union pitch: Bigger Medicare drug price negotiations

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Cancer drug shortages should be causing more outrage

AstraZeneca chief proposes a novel edit to the drug pricing bill

How to save PrEP access — and even expand it

Stem cell treatment guidelines are released by FDA

Activists slam private health insurers over coverage restrictions

Crinetics acromegaly drug succeeds in late

New air purifier tech could be key to improving indoor air quality

What American doctors can learn from their Israeli counterparts

Duchenne breakthrough therapy leaves behind pioneering families

Amazon on where the company's health care bets are headed next

explore

Ancient Greek ideas underpin modern concepts of pregnancy

Ancient Greek ideas underpin modern concepts of pregnancy

A rare thyroid diagnosis led to unexpected, all

What American doctors can learn from their Israeli counterparts

First over

How generative AI is inspiring dreams of a health data revolution

hotspot

hotspot

entertainment

focus